Solving the Problem of γ-Retroviral Vectors Containing Long Terminal Repeats
Open Access
- 1 February 2011
- journal article
- Published by Elsevier BV in Molecular Therapy
- Vol. 19 (2), 229-231
- https://doi.org/10.1038/mt.2010.305
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Stem-Cell Gene Therapy for the Wiskott–Aldrich SyndromeThe New England Journal of Medicine, 2010
- Efficient construction of producer cell lines for a SIN lentiviral vector for SCID-X1 gene therapy by concatemeric array transfectionBlood, 2009
- The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapyJCI Insight, 2009
- Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patientsJCI Insight, 2008
- Physiological Promoters Reduce the Genotoxic Risk of Integrating Gene VectorsMolecular Therapy, 2008
- Self-inactivating Gammaretroviral Vectors for Gene Therapy of X-linked Severe Combined ImmunodeficiencyMolecular Therapy, 2008
- Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapyJCI Insight, 2007
- Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integrationNature Biotechnology, 2006
- Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1Nature Medicine, 2006
- LMO2 -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1Science, 2003